Targeted nanoliposomes to improve enzyme replacement therapy of Fabry disease.

Autor: Tomsen-Melero J; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain., Moltó-Abad M; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Clinical Biochemistry, Drug Delivery & Targeting (CB-DDT), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Merlo-Mas J; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Díaz-Riascos ZV; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Clinical Biochemistry, Drug Delivery & Targeting (CB-DDT), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Functional Validaton & Preclinical Research (FVPR)/U20 ICTS Nanbiosis, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Cristóbal-Lecina E; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), c/ Jordi Girona 18-26, 08034 Barcelona, Spain., Soldevila A; Leanbio SL, 08028 Barcelona, Spain., Altendorfer-Kroath T; JOANNEUM RESEARCH-Institute for Biomedical Research and Technologies (HEALTH), Neue Stiftingtalstraße 2, 8010 Graz, Austria., Danino D; Cryo-EM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel.; Cryo-EM and Self-Assembly Laboratory, Guangdong-Technion Israel Institute of Technology, Shantou, China., Ionita I; Cryo-EM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel., Pedersen JS; Department of Chemistry and Interdisciplinary Nanoscience Center (iNANO), Aarhus University, DK-8000 Aarhus C, Denmark., Snelling L; Labcorp Drug Development, Harrogate HG3 IPY, UK., Clay H; Labcorp Drug Development, Harrogate HG3 IPY, UK., Carreño A; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain., Corchero JL; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Departament de Genètica i de Microbiologia, Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Pulido D; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), c/ Jordi Girona 18-26, 08034 Barcelona, Spain., Casas J; Institut de Química Avançada de Catalunya (IQAC-CSIC), c/ Jordi Girona 18-26, 08034 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain., Veciana J; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain., Simó Schwartz Jr; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Clinical Biochemistry, Drug Delivery & Targeting (CB-DDT), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Servei de Bioquímica, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., Sala S; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Font A; Leanbio SL, 08028 Barcelona, Spain., Birngruber T; JOANNEUM RESEARCH-Institute for Biomedical Research and Technologies (HEALTH), Neue Stiftingtalstraße 2, 8010 Graz, Austria., Royo M; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), c/ Jordi Girona 18-26, 08034 Barcelona, Spain., Córdoba A; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Ventosa N; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain., Abasolo I; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Clinical Biochemistry, Drug Delivery & Targeting (CB-DDT), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Functional Validaton & Preclinical Research (FVPR)/U20 ICTS Nanbiosis, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.; Servei de Bioquímica, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain., González-Mira E; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.

Publikováno v: Science advances [Sci Adv] 2024 Dec 13; Vol. 10 (50), pp. eadq4738. Date of Electronic Publication: 2024 Dec 13.

Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion.

Autor: Martínez-Miguel M; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Castellote-Borrell M; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain., Köber M; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Kyvik AR; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Tomsen-Melero J; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Vargas-Nadal G; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain., Muñoz J; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain., Pulido D; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.; Unidad de Péptidos, UB, Unidad asociada al CSIC por el IQAC, Barcelona 08028, Spain., Cristóbal-Lecina E; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.; Unidad de Péptidos, UB, Unidad asociada al CSIC por el IQAC, Barcelona 08028, Spain., Passemard S; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain., Royo M; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), Barcelona 08034, Spain., Mas-Torrent M; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Veciana J; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Giannotti MI; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.; Nanoprobes and Nanoswitches group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona 08028, Spain.; Departament de Ciència dels Materials i Química Física, Universitat de Barcelona, Barcelona 08028, Spain., Guasch J; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.; Dynamic Biomimetics for Cancer Immunotherapy, Max Planck Partner Group, ICMAB-CSIC, Campus UAB, Bellaterra 08193, Spain., Ventosa N; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain., Ratera I; Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, Bellaterra 08193, Spain.; Biomedical Research Networking Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2022 Oct 26; Vol. 14 (42), pp. 48179-48193. Date of Electronic Publication: 2022 Oct 17.

Overcoming Resistance in Anderson–Fabry Disease: Current Therapeutic Challenges and Future Perspectives.

Autor: Carella, Maria Cristina¹ (AUTHOR) m.carella31@phd.uniba.it, Forleo, Cinzia¹ (AUTHOR) cinzia.forleo@uniba.it, Caretto, Pierpaolo¹ (AUTHOR) p.caretto@studenti.uniba.it, Naccarati, Maria Ludovica¹ (AUTHOR) marialudovica97@libero.it, Dentamaro, Ilaria¹ (AUTHOR) ilaria.dentamaro@policlinico.ba.it, Dicorato, Marco Maria¹ (AUTHOR) m.dicorato20@studenti.uniba.it, Basile, Paolo¹ (AUTHOR) paolo.basile@uniba.it, Carulli, Eugenio² (AUTHOR) e.carulli@phd.uniba.it, Latorre, Michele Davide¹ (AUTHOR) micheledavide.latorre@policlinico.ba.it, Baggiano, Andrea³ (AUTHOR) andrea.baggiano@cardiologicomonzino.it, Pontone, Gianluca^3,4 (AUTHOR) gianluca.pontone@cardiologicomonzino.it, Ciccone, Marco Matteo¹ (AUTHOR) marcomatteo.ciccone@uniba.it, Guaricci, Andrea Igoren¹ (AUTHOR) andreaigoren.guaricci@uniba.it

Publikováno v: Journal of Clinical Medicine. Dec2024, Vol. 13 Issue 23, p7195. 14p.

Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment.

Autor: Tomsen-Melero J; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., Passemard S; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., García-Aranda N; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Drug Delivery and Targeting, and Functional Validation and Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Díaz-Riascos ZV; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Drug Delivery and Targeting, and Functional Validation and Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., González-Rioja R; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., Nedergaard Pedersen J; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, DK-8000 Aarhus C, Denmark.; Department of Chemistry, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark., Lyngsø J; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, DK-8000 Aarhus C, Denmark.; Department of Chemistry, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark., Merlo-Mas J; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Cristóbal-Lecina E; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain., Corchero JL; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Departament de Genètica i de Microbiologia, Institut de Biotecnologia i de Biomedicina (IBB), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Pulido D; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain., Cámara-Sánchez P; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Drug Delivery and Targeting, and Functional Validation and Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Portnaya I; CryoEM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel., Ionita I; CryoEM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel., Schwartz S Jr; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Drug Delivery and Targeting, CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Veciana J; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., Sala S; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Royo M; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Institut de Química Avançada de Catalunya (IQAC-CSIC), 08034 Barcelona, Spain., Córdoba A; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, Spain., Danino D; CryoEM Laboratory of Soft Matter, Faculty of Biotechnology and Food Engineering, Technion-Israel Institute of Technology, 32000 Haifa, Israel.; Faculty of Biotechnology and Food Engineering, Guangdong Technion-Israel Institute of Technology, Daxue Road, Shantou 515063, Guangdong Province, China., Pedersen JS; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, DK-8000 Aarhus C, Denmark.; Department of Chemistry, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark., González-Mira E; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain., Abasolo I; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.; Drug Delivery and Targeting, and Functional Validation and Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain., Ventosa N; Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain.; Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Feb 24; Vol. 13 (7), pp. 7825-7838. Date of Electronic Publication: 2021 Feb 14.

Development of nanoparticles for pharmaceutical preparations using supercritical techniques.

Autor: Islam, Tariqul¹, Al Ragib, Abdullah², Ferdosh, Sahena³, Uddin, A. B. M. Helal¹, Akanda, Md. Jahurul Haque⁴, Mia, Md. Abdur Rashid¹, D. M., Reddy Prasad⁵, Kamaruzzaman, Bin Yunus³, Sarker, Md. Zaidul Islam^1,6 mdzaidul.sarker@marianas.edu

Publikováno v: Chemical Engineering Communications. 2022, Vol. 209 Issue 12, p1642-1663. 22p.